Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucosal immune and barrier system is a complex, multi-layered defense structure essential for maintaining host homeostasis by separating the internal environment from luminal contents, including pathogens, toxins, and dietary antigens (Vancamelbeke & Vermeire, 2017). It comprises a physical barrier—consisting of the mucus layer, a single layer of epithelial cells, and intercellular tight junctions—and a functional immunological barrier known as the gut-associated lymphoid tissue (GALT) (Turner, 2009). This system facilitates the selective absorption of nutrients and water while actively preventing the translocation of harmful microorganisms and pro-inflammatory molecules into the systemic circulation (Okumura & Takeda, 2017). Dysregulation of this barrier, often referred to as "leaky gut," is a central pathogenic feature in diseases such as inflammatory bowel disease (IBD), celiac disease, and systemic inflammatory response syndrome (Mowat & Agace, 2014). Pharmacological interventions typically target specific molecular components within this system, such as cytokine signaling pathways or lymphocyte trafficking receptors, to restore barrier integrity and dampen chronic mucosal inflammation (Vancamelbeke & Vermeire, 2017).
Modulation of inflammatory cytokine pathways (e.g., TNF-alpha inhibition), stabilization of epithelial tight junctions to reduce permeability, and regulation of mucosal lymphocyte trafficking to the gut (Vancamelbeke & Vermeire, 2017).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosal immune and barrier system.